Artelo Biosciences (Artelo Biosciences) 3-Year ROIIC % : -11,157.45% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Artelo Biosciences 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Artelo Biosciences's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was -11,157.45%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Artelo Biosciences's 3-Year ROIIC % or its related term are showing as below:

ARTLW's 3-Year ROIIC % is ranked worse than
99.22% of 1419 companies
in the Biotechnology industry
Industry Median: -13.61 vs ARTLW: -11157.45

Artelo Biosciences 3-Year ROIIC % Historical Data

The historical data trend for Artelo Biosciences's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artelo Biosciences 3-Year ROIIC % Chart

Artelo Biosciences Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

3-Year ROIIC %

Get a 7-Day Free Trial

-217.40

-9,829.17

-11,157.45

Artelo Biosciences Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
3-Year ROIIC %	Get a 7-Day Free Trial															-	-	-	-11,157.45	-

Competitive Comparison of Artelo Biosciences's 3-Year ROIIC %

For the Biotechnology subindustry, Artelo Biosciences's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artelo Biosciences's 3-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artelo Biosciences's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Artelo Biosciences's 3-Year ROIIC % falls into.

Artelo Biosciences 3-Year ROIIC % Calculation

Artelo Biosciences's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %	=	3-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	3-Year Incremental Invested Capital^**
	=	( -9.93 (Dec. 2023) - -4.686 (Aug. 2020) )	/	( 2.086 (Dec. 2023) - 2.039 (Aug. 2020) )
	=	-5.244	/	0.046999999999998
	=	-11,157.45%^***

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Artelo Biosciences (NAS:ARTLW) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Artelo Biosciences 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Artelo Biosciences's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Artelo Biosciences (Artelo Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artelo Biosciences Inc (NAS:ARTLW) » Definitions » 3-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

ARTL:USA

Address

505 Lomas Santa Fe, Suite 160, Solana Beach, CA, USA, 92075

Website

https://www.artelobio.com

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing and commercializing treatments that control endocannabinoid system. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.